Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study.
about
Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety.Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid
P2860
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of daclata ...... ive multi-institutional study.
@en
Efficacy and safety of daclata ...... ive multi-institutional study.
@nl
type
label
Efficacy and safety of daclata ...... ive multi-institutional study.
@en
Efficacy and safety of daclata ...... ive multi-institutional study.
@nl
prefLabel
Efficacy and safety of daclata ...... ive multi-institutional study.
@en
Efficacy and safety of daclata ...... ive multi-institutional study.
@nl
P2093
P2860
P356
P1476
Efficacy and safety of daclata ...... ive multi-institutional study.
@en
P2093
Byeong Wook Cho
Byung Seok Lee
Hee Bok Chae
Hong Soo Kim
Il Han Song
Sae Hwan Lee
Seok Bae Kim
Seok Hyun Kim
Tae Hee Lee
Young Woo Kang
P2860
P356
10.3350/CMH.2016.0053
P577
2017-03-16T00:00:00Z